Bausch Health BHC –8.65% stock was plummeting Tuesday after the company delivered disappointing quarterly results and slashed its full-year financial outlook.
The pharmaceutical firm posted earnings of 40 cents a share, lower than the 91 cents a share consensus among analysts tracked by FactSet. Revenue of $1.97 billion for the quarter, which ended in June, also missed expectations of $2.03 billion.
https://www.barrons.com/articles/bausch-health-earnings-stock-price-51660047675
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.